Mehr Informationen: Venue
For its very first edition, held at the innovative biomedical Campus Berlin-Buch, the DECHEMA colloquium will focus on protein modifications and their significant role in the development of new forms of therapy and diagnosis.
We are proud to announce that Alfred Goldberg from the Harvard Medical School will give a keynote lecture on proteasome regulation, with a focus on connecting our understanding of mechanisms to disease therapies. Further fascinating presentations will address the role of protein modifications in signal transduction, protein stability, their usage in Captured Compound Mass Spectrometry, and innovative technologies for protein labeling, glycooptimisation and multimerization.
A poster session and get-together will close the event and provide plenty of time for networking.
You are cordially invited to present your project with a poster, even if there is no reference to protein modification. We have only space for 30 posters! Please send your name and the title of your poster to Daniela Giese (d.giese(at)bbb-berlin.de) as soon as possible.
13:30 Registration open
Chair: Prof. Dr. Thomas Sommer, Max Delbrück Center for Molecular Medicine in the
14:00 Welcome to the Berlin-Buch campus
Prof. Dr. Martin Lohse, Chairman of the Board of Directors and Scientific Director of
the Max Delbrück Center for Molecular Medicine in the Helmholtz Association
14:15 Keynote Lecture
From Understanding Protein Degradation to Disease Therapy: From Cancer, and
Neurodegenerative Disease to Tuberculosis
Prof. Dr. Alfred L. Goldberg, Department of Cell Biology, Havard Medical School
15:10 Chemical biology of Ubiquitin-mediated signal transduction
Dr. Huib Ovaa, Leiden University Medical Center, Department of Chemical
15:35 GlycoExpress™ – A superior platform for the production of biopharmaceuticals
Dr. Lars Stöckl, Director, Glycoprotein Development and PTM Analytics, Glycotope
16:00 Coffee Break
16:20 Tub-tag labeling: A novel efficient and versatile tool for the C-terminal labeling of
Dominik Schumacher, Chemical Biology II, Leibniz-Institute for Molecular
16:45 Multimerization Technologies for Biologics and Toxins
PD Dr. Michael Joachim Sefkow, Celares GmbH
17:10 CCMS: Case Study to differentiate COMT inhibitors with respect to their off-target
Dr. Mathias Dreger, Head of Biochemistry & Bioanalytics, caprotec bioanalytics GmbH
17:35 Kinetic analysis of protein stability reveals age-dependent degradation
Prof. Dr. Matthias Selbach, Max Delbrück Center for Molecular Medicine in the
Helmholtz Association (MDC)
18:00 Get together with Poster Presentation
The meeting is free of charge. Please register online.
The DECHEMA Colloquium is organised by Berlin Partner for Business and Technology GmbH, the Campus Berlin Buch and the DECHEMA e.V..